INOVIO PHARMACEUTICALS, INC. Number of Reportable Segments
INOVIO PHARMACEUTICALS, INC. (INO) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:NumberOfReportableSegments · last filed 2026-08-12
- INOVIO PHARMACEUTICALS, INC. number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- INOVIO PHARMACEUTICALS, INC. number of reportable segments for the quarter ending 2025-03-31 was 1.00 segment.
- INOVIO PHARMACEUTICALS, INC. number of reportable segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. number of reportable segments for fiscal 2024 was 1.00 segment.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-03-12 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |